EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A novel oral combination strategy for malaria treatment based on artemisinin and apigenin co-loaded in silica-doped nutriosomes

Federica Fulgheri, Miriam Ramírez, Maria Letizia Manca, Alessandra Scano, Guido Ennas, Francesca Marongiu, Ines Castangia, Matteo Aroffu, José Esteban Peris, Iris Usach, Xavier Fernàndez-Busquets, Maria Manconi

Travel Medicine and Infectious Disease · 2026

DOI: 10.1016/j.tmaid.2026.103013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Travel Medicine and Infectious Disease, 2026. Verfasst von Federica Fulgheri und 11 weiteren Autor:innen. Beteiligte Einrichtung: Dept. of Life and Environmental Sciences, University of Cagliari, University Campus, S.P. Monserrato-Sestu Km 0.700, Monserrato, CA, 09042, Italy. Hauptthemen laut MEDLINE: Artemisinins, Antimalarials, Apigenin, Silicon Dioxide. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero dell’Istruzione, dell’Università e della Ricerca, Fundación Ramón Areces, Generalitat de Catalunya.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malaria is a major global health problem that causes substantial socioeconomic losses in developing countries and is associated with high morbidity and mortality, particularly in endemic areas. For these reasons, access to effective pharmacological therapies and adequate healthcare services is essential for the prevention, treatment, and control of malaria. In the present study, an advanced oral drug delivery system based on mesoporous silica-doped nutriosomes co-loaded with apigenin and artemisinin was developed to improve malaria therapy. Vesicles were prepared with phosphatidylcholine and increasing amounts of Nutriose® FM06. To stably load apigenin, a carbonate-bicarbonate buffer solution at pH 9 was used as hydrating medium. Unfortunately, this pH condition promoted the degradation of artemisinin, leading to the formation of non-peroxidic analogues, which are known to be less effective in malaria treatment. Nevertheless, the resulting nutriosomes exhibited in vitro antiplasmodial activity, with IC50 and IC90 values against Plasmodium falciparum comparable to those of artemisinin solution. Moreover, when orally administered at the IC90 dose to infected mice, the formulation resulted in survival rates similar to those observed for artemisinin solution. These findings provide an encouraging proof of concept for the proposed formulation. They demonstrate the potential of this delivery strategy to improve oral antimalarial therapy and establish a solid basis for further pharmacological and in vivo investigations aimed at optimizing and fully evaluating the system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArtemisininsAntimalarialsApigeninSilicon DioxideMalariaAnimalsAdministration, OralMicePlasmodium falciparumDrug Delivery SystemsLiposomesFemale

Stichwörter der Autor:innen

ApigeninArtemisininIn vivo testLiposomesMesoporous silicaNutriose® FM06Phospholipid vesiclesPlasmodium falciparum

Substanzen

ArtemisininsAntimalarialsApigeninSilicon DioxideartemisininLiposomes

Autor:innen und Institutionen

  • Dept. of Life and Environmental Sciences, University of Cagliari, University Campus, S.P. Monserrato-Sestu Km 0.700, Monserrato, CA, 09042, Italy.
  • Barcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Rosselló 149-153, Barcelona, 08036, Spain; Nanomalaria Group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona I…
  • Dept. of Life and Environmental Sciences, University of Cagliari, University Campus, S.P. Monserrato-Sestu Km 0.700, Monserrato, CA, 09042, Italy. Electronic address: mlmanca@unica.it.
  • Department of Chemical and Geological Sciences, University of Cagliari and INSTM Unit, SS 554 Bivio per Sestu, Monserrato, CA, 09042, Italy.
  • Department of Pharmacy and Pharmaceutical Technology and Parasitology, University of Valencia, Valencia, 46100, Spain.

Förderung

  • Ministero dell’Istruzione, dell’Università e della Ricerca
  • Fundación Ramón Areces
  • Generalitat de Catalunya

Zitieren

APA

Fulgheri, F., Ramírez, M., Manca, M. L., Scano, A., Ennas, G., Marongiu, F., Castangia, I., Aroffu, M., Peris, J. E., Usach, I., Fernàndez-Busquets, X., & Manconi, M. (2026). A novel oral combination strategy for malaria treatment based on artemisinin and apigenin co-loaded in silica-doped nutriosomes. Travel Medicine and Infectious Disease. https://doi.org/10.1016/j.tmaid.2026.103013

Vancouver

Fulgheri F, Ramírez M, Manca ML, Scano A, Ennas G, Marongiu F, et al. A novel oral combination strategy for malaria treatment based on artemisinin and apigenin co-loaded in silica-doped nutriosomes. Travel Medicine and Infectious Disease. 2026. doi:10.1016/j.tmaid.2026.103013

BibTeX
@article{Fulgheri2026,
  author = {Fulgheri, Federica and Ramírez, Miriam and Manca, Maria Letizia and Scano, Alessandra and Ennas, Guido and Marongiu, Francesca and Castangia, Ines and Aroffu, Matteo and Peris, José Esteban and Usach, Iris and Fernàndez-Busquets, Xavier and Manconi, Maria},
  title = {A novel oral combination strategy for malaria treatment based on artemisinin and apigenin co-loaded in silica-doped nutriosomes},
  journal = {Travel Medicine and Infectious Disease},
  year = {2026},
  doi = {10.1016/j.tmaid.2026.103013}
}
Kostenlos starten →